I-123 Whole Body Scanning: Case Report and Discussion

PURPOSE:In managing differentiated thyroid carcinoma, concern over the stunning that may occur with traditional whole body imaging using I-131 has fostered an interest in using I-123 for this purpose. A case is presented as a focus for discussion of the issues, with special reference to accuracy and the effect thereon of technical factors. CASE REPORT:A 43-year-old man with papillary carcinoma of the thyroid was scanned after thyroidectomy using 10 mCi I-123. Images at 24 and 48 hours demonstrated foci including multiple regional metastases. They were less well demonstrated in images 7 days after therapeutic I-131, and negative imaging 1 year later implied therapeutic success. DISCUSSION:I-131 has the advantages of a longer half-life, facilitating delayed imaging and lower price. I-123 has the advantages of favorable γ-ray energy and less useless radiation to thyroid tissue and the whole body. Despite its short half-life, with a sufficient amount, images at 48 hours are practical. In the case presented, there are several possible reasons why superior lesion detection occurred in diagnostic I-123 images. In any case, the outcome demonstrates that I-131 posttherapy images are not an absolute “gold standard” for accuracy. Investigations comparing I-123 with I-131 imaging have been subject to biases, including insufficient dose of I-123, lack of delayed I-123 imaging, suboptimal collimation for I-131, and the relatively high dose of I-131 in posttherapy scanning. CONCLUSIONS:The evidence, although not definitive, strongly suggests that I-123 is at least as accurate for diagnostic whole body imaging as I-131.